American Covid in England: What XFG Means, Latest Symptoms and the Real Risks
Dr Farrukh M SheikhThe headlines sound alarming, but what does ‘American Covid’ actually mean? England’s latest figures show more COVID-19 activity, while health officials say there is no current evidence that the XFG variant causes more severe illness. Here is what the numbers — and the NHS advice — tell us.
In 30 Seconds
‘American Covid’ is an informal media label for the XFG (Stratus) lineage, not a new disease or proof that the virus originated in the United States. UKHSA says XFG has circulated for around a year. In England, hospital COVID-19 test positivity rose to 9.1% and the weekly hospital admission rate to 2.04 per 100,000 in the week ending 4 October 2026. COVID-19 activity is increasing but remains at a low level overall. There is no current evidence that XFG causes more severe illness than other circulating variants. [1,2]
Get the full article in your inbox
Receive this article as a PDF and stay up to date with important new health research, medical developments and scientific discoveries — explained clearly, compassionately and without the hype.
What the News Is Saying
On 8 October 2026, the UK Health Security Agency (UKHSA) explained why ‘American Covid’ has appeared in news headlines. The name refers to XFG, also known as Stratus, which UKHSA describes in its public explainer as the most common current variant. The surveillance report’s published sequencing window (31 August–13 September), however, ranked several other lineages above XFG, reflecting different evidence windows. It reflects where the variant was first sequenced and detected — not proof of where it first emerged. [1]
At the same time, UKHSA’s surveillance report for England shows increases in some infection and hospital indicators. That is a real public-health trend, but it is not evidence of an unusually dangerous new virus. [2]
What exactly is XFG — and why “American”?
Viruses change as they spread. Scientists track these changes by sequencing samples and grouping closely related viruses into lineages. XFG is one such SARS-CoV-2 lineage, and Stratus is its informal nickname. ‘American Covid’ is a media label, not an official diagnostic term. [1]
UKHSA says XFG has been circulating in the UK and elsewhere for approximately a year. The place where a variant is first detected depends partly on where sequencing happens, so detection location should not be confused with origin. [1]
What do England’s latest numbers actually show?
The report published on 8 October covers surveillance week 40 (28 September to 4 October 2026). It reports rising COVID-19 activity across some indicators, while classifying activity overall as low. [2]
Hospital-setting PCR positivity: 9.1%, up from 7.9% on the previous Sunday. Weekly hospital admission rate: 2.04 per 100,000 people, up from 1.75. Weekly intensive-care/high-dependency admission rate: 0.06 per 100,000, compared with 0.05 previously. [2]
A different surveillance stream — GP sentinel swabbing — found COVID-19 positivity of 10.8%, broadly unchanged from 10.9% the previous week. The figures describe different tested populations, so they must not be treated as directly interchangeable. [2]
Importantly, a 9.1% positivity rate is the proportion of tests that were positive in the hospital surveillance sample. It does not mean 9.1% of everyone in England has COVID-19. [2]
Headline versus evidence
HEADLINE: ‘American Covid’ is sweeping England.
EVIDENCE: UKHSA is observing an increase in COVID-19 activity, but the current overall level is low. XFG has been present for months; the data do not establish that XFG alone caused the recent rise or that it leads to more severe illness. [1,2]
Does XFG have different symptoms?
The NHS lists familiar COVID-19 symptoms: high temperature, a new continuous cough, sore throat, fatigue, headache, runny or blocked nose, aching body, changes to smell or taste, breathlessness, and sometimes stomach symptoms. Many overlap with colds and flu. [3]
Reports about hoarse or unusually painful throats may draw attention, but symptoms alone cannot reliably tell you which SARS-CoV-2 lineage you have. UKHSA’s October briefing does not establish a unique XFG symptom pattern. [1,3]
Who should pay particular attention?
Older adults and people with weakened immune systems remain important groups to protect. UKHSA’s week 40 report records the highest hospital admission rate in people aged 85 and over: 20.30 per 100,000, up from 16.46 in the preceding week. [2]
Some people with specific serious health conditions may qualify for an NHS assessment for early COVID-19 treatments, but this is not the same as saying that every older adult qualifies. Anyone who believes they may be eligible should check NHS criteria and contact their GP or specialist promptly if they develop symptoms and test positive. [4]
What can you do?
If you have a high temperature or feel too unwell to carry on with normal activities, NHS advice is to try to stay at home and avoid contact with others. If you test positive, adults are advised to try to avoid other people for five days after the test and avoid those at higher risk for ten days. Guidance differs for children. [3]
If you must go out while unwell, consider a well-fitting face covering, avoid crowded poorly ventilated spaces, and practise good hand and cough hygiene. [1,5]
For most people, rest, fluids and appropriate symptom relief are enough. But do not ignore worsening symptoms. Contact NHS 111 or seek urgent GP advice if symptoms are worsening or not improving. Sudden chest pain or severe breathing difficulty requires emergency help — call 999. [3]
For England’s autumn 2026 programme, routine COVID-19 vaccination is offered to adults aged 75 and over, older-adult care-home residents, and people aged six months or over who are immunosuppressed under the programme’s eligibility criteria. Being aged 60–74 alone does not automatically qualify someone for this campaign. [6]
Here’s the catch — what remains uncertain?
COVID-19 surveillance measures different things: positive tests, consultations, hospital admissions and lineage frequencies. Testing patterns and reporting delays can change these measurements. None of the current figures proves the cause of an individual illness or predicts exactly how the winter will unfold. [2]
UKHSA currently sees no evidence of greater severity from XFG, but that is not the same as declaring all COVID-19 infections harmless. Risk still depends on factors including age, health conditions and immune status. [1,3,4]
UKHSA is also monitoring other lineages, including BA.3.2 (‘Cicada’), which WHO regards as a variant under monitoring with limited evidence and low assessed public-health risk at present. [1]
Reader Takeaway
The phrase ‘American Covid’ makes a familiar virus sound new. The more useful story is that COVID-19 activity in England has increased as autumn progresses, although current surveillance still classifies overall activity as low. XFG has been circulating for around a year and there is no present evidence that it causes more severe illness.
Pay attention to symptoms, protect vulnerable people, check whether you qualify for autumn vaccination or early treatment, and seek help promptly for serious warning signs. [1–6]
Updates to This Story
8 October 2026 — Initial evidence snapshot prepared using UKHSA’s same-day explainer and surveillance report for week 40 (28 September–4 October). This entry will remain in place when later dated updates are added.
Next View Point
Review UKHSA’s next published surveillance report for changes in hospital positivity, admissions, critical-care impact and lineage distribution, or sooner if UKHSA/WHO changes its assessment of XFG severity. Add new findings as dated updates without overwriting this original snapshot.
Sources & Further Reading
[1] UKHSA, Should we be worried about the current COVID-19 variants? (8 Oct 2026)
[2] UKHSA, National flu and COVID-19 surveillance report: week 41 (8 Oct 2026)
[3] NHS, COVID-19 symptoms and what to do
[4] NHS, Treatments for COVID-19
[5] NHS, How to avoid catching and spreading COVID-19
[6] GOV.UK, Autumn 2026 vaccination eligibility
Health Note
This article provides general public-health information for readers in England, not individual diagnosis or treatment advice. Advice and vaccine eligibility may change. Consult current NHS guidance and seek appropriate medical help when needed.